Control of Endothelin-A Receptor Expression by Progesterone Is Enhanced by Synergy With Gata2

被引:14
作者
Zhang, Yanping
Knutsen, Gregory R.
Brown, Matthew D.
Ruest, L. Bruno [1 ]
机构
[1] Texas A&M Univ, Baylor Coll Dent, Dept Biomed Sci, Dallas, TX 75246 USA
基金
美国国家卫生研究院;
关键词
SMOOTH-MUSCLE-CELLS; ORAL-CONTRACEPTIVES; GENE-EXPRESSION; BREAST-CANCER; PERIODONTAL CHANGES; SIGNALING PATHWAYS; HUMAN-ENDOMETRIUM; HUMAN MYOMETRIUM; PRIMARY CULTURE; B-RECEPTOR;
D O I
10.1210/me.2012-1334
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The endothelin-A receptor (Ednra) is involved in several physiological, pathological, and developmental pathways. Known for its function in vasoconstriction after being activated by endothelin-1, Ednra also controls cephalic neural crest cell development and appears to play a role in several pathologies, including cancer and periodontitis. However, the mechanisms regulating Ednra expression have not been identified despite its important functions. In this study, we investigated the role progesterone plays in Ednra gene expression in vivo and in vitro. In mice, pregnancy promotes Ednra expression in the heart, kidney, lung, uterus, and placenta, and the up-regulation is mediated by progesterone. We determined that the conserved region between -5.7 and -4.2 kb upstream of the mouse Ednra gene is necessary for the progesterone response. We also found that progesterone mediates Ednra activation through progesterone receptor B activation by its recruitment to PRE6, one of the 6 progesterone response elements found in that locus. However, gene activation by means of a GATA2 site was also necessary for the progesterone response. The Gata2 transcription factor enhances the progesterone response mediated by the progesterone receptor B. Together these results indicate that progesterone regulates Ednra expression by synergizing with Gata2 activity, a previously unknown mechanism. This mechanism may have an impact on pathologies involving the endothelin signaling.
引用
收藏
页码:892 / 908
页数:17
相关论文
共 81 条
  • [1] [Anonymous], 2012, Molecular Cloning: A Laboratory Manual
  • [2] Aparicio Oscar, 2005, Curr Protoc Mol Biol, VChapter 21, DOI 10.1002/0471142727.mb2103s69
  • [3] ET(A) AND ET(B) ENDOTHELIN RECEPTORS IN HUMAN MYOMETRIUM CHARACTERIZED BY THE SUBTYPE-SELECTIVE LIGANDS BQ123, BQ3020, FR139317 AND PD151242
    BACON, CR
    MORRISON, JJ
    OREILLY, G
    CAMERON, IT
    DAVENPORT, AP
    [J]. JOURNAL OF ENDOCRINOLOGY, 1995, 144 (01) : 127 - 134
  • [4] Modulation of AP-1 activity by the human progesterone receptor in endometrial adenocarcinoma cells
    Bamberger, AM
    Bamberger, CM
    Gellersen, B
    Schulte, HM
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1996, 93 (12) : 6169 - 6174
  • [5] Endothelin: 20 years from discovery to therapy
    Barton, Matthias
    Yanagisawa, Masashi
    [J]. CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY, 2008, 86 (08) : 485 - 498
  • [6] BERGERON C, 1988, LAB INVEST, V59, P862
  • [7] Boron W.Boulpaep., 2005, MED PHYSL CELLULAR M, V2nd
  • [8] Expression of the progesterone receptor and progesterone-metabolising enzymes in the female and male human kidney
    Bumke-Vogt, C
    Bähr, V
    Diederich, S
    Herrmann, SM
    Anagnostopoulos, I
    Oelkers, W
    Quinkler, M
    [J]. JOURNAL OF ENDOCRINOLOGY, 2002, 175 (02) : 349 - 364
  • [9] Matlnspector and beyond: promoter analysis based on transcription factor binding sites
    Cartharius, K
    Frech, K
    Grote, K
    Klocke, B
    Haltmeier, M
    Klingenhoff, A
    Frisch, M
    Bayerlein, M
    Werner, T
    [J]. BIOINFORMATICS, 2005, 21 (13) : 2933 - 2942
  • [10] DIFFERENTIAL GENE ACTIVATION BY GLUCOCORTICOIDS AND PROGESTINS THROUGH THE HORMONE REGULATORY ELEMENT OF MOUSE MAMMARY-TUMOR VIRUS
    CHALEPAKIS, G
    ARNEMANN, J
    SLATER, E
    BRULLER, HJ
    GROSS, B
    BEATO, M
    [J]. CELL, 1988, 53 (03) : 371 - 382